Example: Heart Attack

Clinical Trials on Tick-borne Encephalitis

Total 38 results

NCT04648241

Active, not recruiting

Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older

Conditions: Tick-Borne Encephalitis
NCT02318069

Completed

New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Conditions: Tick-borne Encephalitis
NCT01582698

Completed

TBE Seropersistence up to 10 Years After First Booster in Adults

Conditions: Tick-borne Encephalitis (TBE)
NCT03956446

Recruiting

Tick-borne Encephalitis and Borrelial Antibodies in Serum

Conditions: Tick Borne Encephalitis
NCT04573205

Not yet recruiting

Primary TBE Vaccination for the Elderly

Conditions: Tick-borne Encephalitis, Vaccine
NCT01991067

Completed

Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients

Conditions: Tick Borne Encephalitis
NCT04017052

Active, not recruiting

Application of a TBE-Vaccine in Obese Persons

Conditions: Tick Borne Encephalitis
NCT03958058

Completed

Tick-borne Encephalitis and Possible Borrelial Serology

Conditions: Tick Borne Encephalitis, Lyme Disease
NCT03932448

Recruiting

Fever After Tick Bite Study

Conditions: Tick-Bite; Fever, Tick Fever, Tick-Borne Diseases, Encephalitis, Tick-Borne, Tick Bites
NCT00894686

Completed

Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)

Conditions: Encephalitis, Tick-Borne
NCT02463942

Unknown status

Tick-borne Encephalitis and Positive Borrelial Antibodies

Conditions: Tick-borne Encephalitis
NCT01562444

Completed

Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules

Conditions: Tick Borne Encephalitis
NCT01710189

Completed

Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac

Conditions: Tick-Borne Encephalitis
NCT01031537

Terminated

Vaccine Study for Tick-Borne Encephalitis Virus (TBEV)

Conditions: Tick-Borne Encephalitis, Encephalitis, Tick-Borne, Tick-Borne Disease, Glycoprotein E, Flavivirus, NSI Protein, Flavivirus
NCT01361776

Completed

Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Conditions: Tick-borne Encephalitis
NCT00840801

Completed

Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children

Conditions: Encephalitis, Tick-Borne
NCT00460486

Completed

Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule

Conditions: Encephalitis, Tick-Borne
NCT00503529

Completed

TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)

Conditions: Encephalitis, Tick-Borne
NCT00163618

Completed

Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children

Conditions: Encephalitis, Tick-borne
NCT00163540

Completed

Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)

Conditions: Encephalitis, Tick-borne
NCT00161967

Completed

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

Conditions: Encephalitis, Tick-Borne
NCT00161954

Completed

Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years

Conditions: Encephalitis, Tick-borne
NCT00161889

Completed

FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years

Conditions: Encephalitis, Tick-borne
NCT00161876

Completed

FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years

Conditions: Encephalitis, Tick-borne
NCT00161863

Completed

Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

Conditions: Tick-borne Encephalitis